GTC presented abstracts at AACR 2023
GTC’s posters from 2023 Convention of American Association for Cancer Research are now available to be downloaded. Please reach out with any questions.
Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms
The Molecular Landscape of Premenopausal Versus Postmenopausal Breast Cancer in Patients Without Inherited Predisposition Mutations
Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer
Read more Articles and News from GTC
Genomic Testing Cooperative to Exhibit and Present Research at 2026 ASCO Annual Meeting
GTC will spotlight DNA and RNA-based precision oncology testing, liquid biopsy applications and research across hematologic malignancies, breast cancer metastasis and CNS involvement CHICAGO, May
GTC and Dr. Maher Albitar Featured in Houston Business Journal
Genomic Testing Cooperative and its founder and CEO, Dr. Maher Albitar, were recently featured in the Houston Business Journal in a “Face to Face” profile highlighting
ASCO 2026 Abstracts
Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Defining APOBEC-like signature in diffuse large B-cell lymphoma and demonstration of distinct transcriptomic profile. Presenter: Adam Albitar, MD
GTC opens Houston laboratory, expanding national precision oncology network
New central U.S. location strengthens testing capacity and turnaround times while positioning GTC within the Texas Medical Center ecosystem HOUSTON — March 12, 2026 — Genomic